- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Lennox-Gastaut syndrome Dravet syndrome
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1428KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 116KB)
Cannabidiol – July 2020
Cannabidiol: Oral solution, 100 mg per mL, 100 mL; Epidyolex®
Last updated
30 October 2020